# 510(k) SUMMARY

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

The assigned 510(k) umber K092849.

# Summary Prepared:

Sept 11, 2009

Submitted by:

Epocal Inc.   
2060 Walkley Road, Ottawa, Ontario, Canada K1G 3P5 Telephone: (613) 738-6192   
Fax: (613) 738-6195

# Contact:

Roy Layer Director of Quality Assurance and Regulatory Affairs.

# 5.1 Identification of the Device

Device Name:   
Proprietary / Trade Name:   
Common Name:   
Classification Name:   
Device Classification:   
Regulation Number:   
Panel:   
Product Code:

epoc® Blood Analysis System epoc Blood Analysis System Portable Blood Analyzer See Table 5.1 Below See Table 5.1 Below See Table 5.1 Below See Table 5.1 Below See Table 5.1 Below

Figure 5.1 - Table - epoc™ Blood Analysis System with Blood Gas, Electrolytes and Metabolytes (BGEM) Test Card   

<table><tr><td rowspan=1 colspan=1>Name</td><td rowspan=1 colspan=1>Class</td><td rowspan=1 colspan=1>RegulationNumber</td><td rowspan=1 colspan=1>Panel</td><td rowspan=1 colspan=1>ProductCode</td></tr><tr><td rowspan=1 colspan=1>Electrode Measurement, Blood-Gases (PCO2, PO2) and Blood pH</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.1120</td><td rowspan=1 colspan=1>ClinicalChemistry</td><td rowspan=1 colspan=1>CHL</td></tr><tr><td rowspan=1 colspan=1>Electrode, Ion Specific,,Sodium</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.1665</td><td rowspan=1 colspan=1>ClinicalChemistry</td><td rowspan=1 colspan=1>JGS</td></tr><tr><td rowspan=1 colspan=1>Electrode, Ion Specific, Potassium</td><td rowspan=1 colspan=1>I1</td><td rowspan=1 colspan=1>862.1600</td><td rowspan=1 colspan=1>ClinicalChemistry</td><td rowspan=1 colspan=1>CEM</td></tr><tr><td rowspan=1 colspan=1>Electrode,Ion Specific,Calcium</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.1145</td><td rowspan=1 colspan=1>ClinicalChemistry</td><td rowspan=1 colspan=1>JFP</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.1345</td><td rowspan=1 colspan=1>ClinicalChemistry</td><td rowspan=1 colspan=1>CGA</td></tr><tr><td rowspan=1 colspan=1>Hematocrit</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>864.6400</td><td rowspan=1 colspan=1>Hematology</td><td rowspan=1 colspan=1>JPI</td></tr></table>

# 5.2 Identification of the Predicate Device i-STAT® Model 300 Portable Clinical Analyzer

# 5.3 Description of the New Device

The epoc System is a point-of-care device currently in use in hospitals. The epoc System was previously cleared for use with arterial and venous blood in 510(k) submissions K061597 and K090109. In this submission we are seeking clearance to use capillary blood specimens on the epoc System and to remove the limiting labeling regarding the glucose test using neonatal samples.

The epoc Blood Analysis System consists of three (3) components:

. epoc Test Card

The single use blood test card comprises a port for introduction of a blood sample to an array of sensors on a sensor module. The sensor module is mounted proximal to a fluidic channel contained in a credit-card sized housing. The card has an on-board calibrator contained in a sealed reservoir fluidically connected to the senor array through a valve.

# epoc Card Reader

The reader is a minimally featured raw-signal acquisition peripheral. The reader comprises a card orifice for accepting a test card, and a mechanical actuation assembly for engaging the test card after it is inserted into the card orifice. Within the reader's card orifice there is a bar code scanner, an electrical contact array for contacting the card's sensor module, and a thermal subsystem for heating the card's measurement region to $3 7 ^ { \circ } C$ during the test. The reader also comprises circuits for amplifying, digitizing and converting the raw sensor signals to a wireless transmittable Bluetooth™ format,

# 3. epoc Host

The host is a dedicated-use Personal Digital Assistant (PDA) computing device with custom software that displays the test results. The reader and host computer together constitute all of the subsystems generally found in a traditional analyzer that operates on unit-use sensors and reagents

# 5.3.1 epoc Care-Fill Capillary Tube

The epoc Care-Fill Capillary Tube has been developed to introduce capillary samples into the epoc Test card. The epoc Care-Fill Capillary Tube is intended for use only with epoc Blood Analysis System and is the only method, other than using a syringe, to introduce samples into the epoc test cards.

# 5.4 Intended Use of the Device

The epoc System .is intended for use by trained medical professionals as an in vitro diagnostic device for the quantitative testing of samples of heparinized or unanticoagulated arterial, venous, or capillary whole blood in the laboratory or at the point of care in hospitals, nursing homes or other clinical care institutions.

The BGEM test card panel configuration includes sensors for sodium (Na), potassium (K), ionized calcium (iCa), pH, $p { \bar { \mathsf { C } } } { \mathsf { O } } _ { 2 } , p { \mathsf { O } } _ { 2 } ,$ glucose (Gluc) and hematocrit (Hct).

Care-Fill Capillary Tubes are intended for use with the epoc Blood Analysis System and are used for the collection and dispensing of capillary blood samples with epoc Test Cards.

5.5 Comparison of Technological Characteristics To Predicate Device   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>epoc Blood Analysis System</td><td rowspan=1 colspan=1>i-STAT Model 300</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>510(k) #</td><td rowspan=1 colspan=1>K061597 and K090109</td><td rowspan=1 colspan=1>K001387</td><td rowspan=1 colspan=1>Same/</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td><td rowspan=1 colspan=1>Different</td></tr><tr><td rowspan=1 colspan=1>Intendeduse</td><td rowspan=1 colspan=1>The epoc Blood Analysis System isintended for use by trained medicalprofessionals as an in vitro diagnosticdevice for the quantitative testing ofsamples of whole blood using theBGEM (Blood Gas ElectrolyteMetabolyte), BGE (Blood GasElectrolyte) and ABG (Arterial BloodGas) test card panels.</td><td rowspan=1 colspan=1>The i-STAT Model 300 Portable ClinicalAnalyzer is intended to be used bytrained medical professionals for usewith i-STAT test cartridges andMediSense blood glucose test strips.i-STAT cartridges comprise a varietyof clinical chemistry tests and testpanels.</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Where used</td><td rowspan=1 colspan=1>hospital</td><td rowspan=1 colspan=1>hospital</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Measuredparameters</td><td rowspan=1 colspan=1>pH, pCO2, pOz, Na, K, iCa, Gluc, Hct</td><td rowspan=1 colspan=1>pH, pCO2, pO2, Na, K, iCa, Gluc, Hct</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>CalCculatedparameters</td><td rowspan=1 colspan=1>TCO2, HCO3,BE,SO2,Hgb</td><td rowspan=1 colspan=1>TCO2, HCO3,BE,sO2,Hgb</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Sample type</td><td rowspan=1 colspan=1>Venous, arterial and capiflary wholeblood</td><td rowspan=1 colspan=1>Venous, arterial and capillary wholeblood</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Reportableranges</td><td rowspan=1 colspan=1>pH     6.5- 8.0       pH unitspCO2  5 - 250         mm HgpO2    5 - 750         mm HgNa     85 -180        mmol/LK      1.5 - 12         mmol/LiCa     0.25 - 4         mmol/LGlu     20 - 700        mg/dLHct    10 - 75         %PCVTCO2   1-85           mmol/LHCO3  1-85           mmol/LBEecf   -30 - +30       mmol/LBED     -30 - +30       mmol/LsO2    0 - 100          %Hb     3.3-25         g/dL</td><td rowspan=1 colspan=1>pH     6.5-8.2        pH unitspCO  5 - 130         mm HgpO2    5 - 800          mm HgNa     100 - 180       mmol/LK      2.0 - 9.0        mmol/LiCa     0.25 - 2.5      mmol/LGlu    20 - 700        mg/dLHct    10 -75         %PCVTCO2   5 - 50           mmol/LHCO3  1 -85           mmol/LBEect   -30 - +30       mmol//LBED    -30 - +30       mmol/LsO2    0 - 100          %Hb     3-26           g/dL</td><td rowspan=1 colspan=1>differentdifferentsamedifferentdifferentdifferentsamesamedifferentsamesamesamesamesame</td></tr><tr><td rowspan=1 colspan=1>Samplevolume</td><td rowspan=1 colspan=1>Non volumetric over 90 μL</td><td rowspan=1 colspan=1>100μL</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Test card</td><td rowspan=1 colspan=1>Unit-use card withon-board calibrator in sealedreservoiran electrochemical multi-sensorarrayport for sample introductionfluid waste chamber</td><td rowspan=1 colspan=1>Unit-use cartridge withon-board catibrator in sealedreservoiran electrochemical multi-sensorarrayport for sample introductionfluid waste chamber</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Test cardstorage</td><td rowspan=1 colspan=1>Room temperature until expiry date</td><td rowspan=1 colspan=1>Storage at 2-8°C until expiry dateincluding max 2 weeks at roomtemperature</td><td rowspan=1 colspan=1>different</td></tr><tr><td rowspan=1 colspan=1>Sensor array</td><td rowspan=1 colspan=1>A laminated foil sensor module</td><td rowspan=1 colspan=1>A micro-fabricated chip-set</td><td rowspan=1 colspan=1>different</td></tr><tr><td rowspan=1 colspan=1>Tests/sensorcomponents</td><td rowspan=1 colspan=1>pH - pVC ion selective electrodepCO -QH modified Severinghaus typepO2 - membrane coated gold cathodeNa - PVC ion selective electrodeK - pvC ion selective electrodeiCa - PVC ion selective electrodeGlu - Enzymatic (glucose oxidasebased), amperometric peroxidedetectionHct - conductivity, gold electrodes</td><td rowspan=1 colspan=1>pH - PVC ion selective electrodepCO2 - QH modified Severinghaus typepO2 - membrane coated gold cathodeNa - PVC ion selective electrodeK - PVC ion selective electrodeiCa - PVC ion selective electrodeGlu - Enzymatic (glucose oxidasebased), amperometric peroxidedetectionHct - conductivity, gold electrodes</td><td rowspan=1 colspan=1>samesamesamesamesamesamesamesame</td></tr><tr><td rowspan=1 colspan=1>Analyzercomponents</td><td rowspan=1 colspan=1>Two housings;1 - The reader comprisingOrifice for test card introductionelectrical connector to cardheater for 37°C operation</td><td rowspan=1 colspan=1>A single housing comprisingOrifice for test card introductionelectrical connector to cardheater for 37°C operation</td><td rowspan=1 colspan=1>differentsamesamesame</td></tr></table>

Figure 5.2 - Table Comparing epoc Device Performance Characteristics With Predicate Device   

<table><tr><td rowspan="18"></td><td rowspan="20">device for 0 o reservoir • sensors • card Thermal controllers MUX A/D device card info</td><td>mechanical card engagement mechanical card engagement device for making electrical contact to card&#x27;s sensors</td></tr><tr><td>0 making electrical contact to card&#x27;s sensors • for rupture of calibrator</td></tr><tr><td>for rupture of calibrator reservoir</td><td>same</td></tr><tr><td>moving calibrator to • moving calibrator to sensors</td><td>same</td></tr><tr><td>engaging heaters with 0 engaging heaters with card</td><td>same</td></tr><tr><td>op-amp sensor signal detectors op-amp sensor signal detectors iQC monitoring devices iQC monitoring devices</td><td>same same</td></tr><tr><td>Thermai controllers MUX</td><td>same same</td></tr><tr><td>A/D Bluetooth stack for wireless wire transmission of digitized raw transmission of digitized raw sensor signals to computing</td><td>same different</td></tr><tr><td>sensor signals to computing subsystem in same housing</td><td></td></tr><tr><td>bar code scanner for acquiring n/a internal and external electronic</td><td>different different</td></tr><tr><td>internal electronic reader self-test circuit self-test circuit 2 - The computing device comprising</td><td></td></tr><tr><td>a PDA microprocessor</td><td>microprocessor</td><td>same</td></tr><tr><td>memory color LCD display keyboard</td><td>memory monochrome LCD display keyboard</td><td>same different same</td></tr><tr><td>i/o for communicating test results to other devices software to control the test and</td><td>i/o for communicating test results to other devices software to control the test and</td><td>same</td></tr><tr><td>calculate analytical values from raw sensor signals</td><td>calculate analytical values from raw sensor signals</td><td>same</td></tr><tr><td>battery operated with rechargeable batteries via plug in</td><td>battery operated with</td><td>same</td></tr><tr><td></td><td>rechargeable batteries via external power supply in</td><td></td></tr><tr><td>plug-in power supply</td><td>downloader cradle</td><td></td></tr><tr><td>Measurement 37°C temperature</td><td>37°C</td><td>same</td></tr><tr><td>Measurement Calibrate test card-introduce sample- measure</td><td>Introduce sample-calibrate test cartridge-measure</td><td>different</td></tr><tr><td></td><td>130-200 sec from sample introduction</td><td></td></tr><tr><td>sequence</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>Measurement</td><td>35sec from sample introduction</td><td></td><td>different</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>time</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>Error</td><td>iQC system to detect user errors</td><td>iQC system to detect user errors</td><td>same</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>iQC system for reader self-check</td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>detection</td><td>iQC system for reader self-check</td><td></td><td>same</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>conformance</td><td>iQC system to detect card non-</td><td>iQC system to detect card non-</td><td>same</td></tr></table>

In this $5 1 0 ( k )$ submission we demonstrate that the epoc System is substantially equivalent to the predicate device when using capillary blood. This submission also includes glucose data on neonatal capillary whole blood and therefore offers ground to remove the current labeling limitation on the epoc glucose test.

# 5.6 Summary of Non-Clinical Test Performance in Support of Substantial Equivalence

# 5.6.1 Equivalence of the epoc Test Results Between Samples Delivered from a Syringe Versus Samples Delivered from Care-Fill Capillary Tubes

Experiments were performed in house to demonstrate that the collection and delivery method using Care-Fill cap tubes yields test results equivalent with those where a syringe is used as a sample delivery method. This study was also used as the only opportunity to test the capillary delivery over extended ranges of the various analytes, as capillary samples are difficult to modify.

The table in Figure 5.3. below shows the results of a method comparison between the two means of sample delivery: $\mathsf { X }$ -syringe and Y-Care-Fill capillary tube.

Figure 5.3 - Table - Summary results of the Care-Fill vs. Syringe method comparison study   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=8>EPOC-CareFill vs EPOC-Syringe</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>pCO2</td><td rowspan=1 colspan=1>p02</td><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>Ca</td><td rowspan=1 colspan=1>Glu</td><td rowspan=1 colspan=1>Hct</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>42</td></tr><tr><td rowspan=1 colspan=1>Sxx</td><td rowspan=1 colspan=1>0.004</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.018</td><td rowspan=1 colspan=1>4.7</td><td rowspan=1 colspan=1>0.41</td></tr><tr><td rowspan=1 colspan=1>Syy</td><td rowspan=1 colspan=1>0.005</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.019</td><td rowspan=1 colspan=1>4.0</td><td rowspan=1 colspan=1>0.60</td></tr><tr><td rowspan=1 colspan=1>intercept</td><td rowspan=1 colspan=1>0.446</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>-0.010</td><td rowspan=1 colspan=1>.2.5</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1>slope</td><td rowspan=1 colspan=1>0.940</td><td rowspan=1 colspan=1>0.885</td><td rowspan=1 colspan=1>0.996</td><td rowspan=1 colspan=1>0.981</td><td rowspan=1 colspan=1>0.981</td><td rowspan=1 colspan=1>0.991</td><td rowspan=1 colspan=1>1.037</td><td rowspan=1 colspan=1>0.946</td></tr><tr><td rowspan=1 colspan=1>Syx</td><td rowspan=1 colspan=1>0.008</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.037</td><td rowspan=1 colspan=1>4.07</td><td rowspan=1 colspan=1>0.7</td></tr><tr><td rowspan=1 colspan=1>Xmin</td><td rowspan=1 colspan=1>6.721</td><td rowspan=1 colspan=1>14.0</td><td rowspan=1 colspan=1>22.7</td><td rowspan=1 colspan=1>102.5</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>0.389</td><td rowspan=1 colspan=1>16.0</td><td rowspan=1 colspan=1>10.5</td></tr><tr><td rowspan=1 colspan=1>X max</td><td rowspan=1 colspan=1>7.555</td><td rowspan=1 colspan=1>143.6</td><td rowspan=1 colspan=1>383.0</td><td rowspan=1 colspan=1>176.0</td><td rowspan=1 colspan=1>12.0</td><td rowspan=1 colspan=1>2.868</td><td rowspan=1 colspan=1>530.5</td><td rowspan=1 colspan=1>76.7</td></tr><tr><td rowspan=1 colspan=1>R{2</td><td rowspan=1 colspan=1>0.997</td><td rowspan=1 colspan=1>0.996</td><td rowspan=1 colspan=1>0.999</td><td rowspan=1 colspan=1>0.994</td><td rowspan=1 colspan=1>0.999</td><td rowspan=1 colspan=1>0.994</td><td rowspan=1 colspan=1>0.998</td><td rowspan=1 colspan=1>0.997</td></tr><tr><td rowspan=1 colspan=1>Decision Levei 1</td><td rowspan=1 colspan=1>7.3</td><td rowspan=1 colspan=1>35</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>135</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>45</td><td rowspan=1 colspan=1>33</td></tr><tr><td rowspan=1 colspan=1>Bias</td><td rowspan=1 colspan=1>0.005</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>-0.018</td><td rowspan=1 colspan=1>-0.8</td><td rowspan=1 colspan=1>-0.18</td></tr><tr><td rowspan=1 colspan=1>Bias 95% Conf. Hi</td><td rowspan=1 colspan=1>0.007</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>-0.007</td><td rowspan=1 colspan=1>0.2</td><td rowspan=1 colspan=1>0.04</td></tr><tr><td rowspan=1 colspan=1>Bias 95% Conf. Lo</td><td rowspan=1 colspan=1>0.003</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>-0.4</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>-0.01</td><td rowspan=1 colspan=1>-0.029</td><td rowspan=1 colspan=1>-1.8</td><td rowspan=1 colspan=1>-0.39</td></tr><tr><td rowspan=1 colspan=1>Decision Level 2</td><td rowspan=1 colspan=1>7.5</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>5.8</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>180</td><td rowspan=1 colspan=1>55</td></tr><tr><td rowspan=1 colspan=1>Bias</td><td rowspan=1 colspan=1>-0.007</td><td rowspan=1 colspan=1>-2.0</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>-0.04</td><td rowspan=1 colspan=1>-0.024</td><td rowspan=1 colspan=1>4.3</td><td rowspan=1 colspan=1>-1.34</td></tr><tr><td rowspan=1 colspan=1>Bias 95% Conf. Hi</td><td rowspan=1 colspan=1>-0.004</td><td rowspan=1 colspan=1>-1.7</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>-0.03</td><td rowspan=1 colspan=1>-0.015</td><td rowspan=1 colspan=1>5.4</td><td rowspan=1 colspan=1>-1.13</td></tr><tr><td rowspan=1 colspan=1>Bias 95% Conf. Lo</td><td rowspan=1 colspan=1>-0.010</td><td rowspan=1 colspan=1>-2.2</td><td rowspan=1 colspan=1>-0.4</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>-0.06</td><td rowspan=1 colspan=1>-0.032</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>-1.54</td></tr></table>

# 5.6.2 In-house Method Comparison study using capillary samples

This study was performed in-house to establish analytical performance versus the predicate device when using capillary blood samples.

The table in Figure 5.4. below shows the results of the study between the two testing methods: X-i-STAT-CG8 using CLINITUBES and Y-epoc-BGEM using Care-Fill.

Table 5.4 - Table - Average readings and biases for epoc/Care-Fill vs. iSTAT/CLINITUBE   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=8>Y: EPOC/CareFilI vs X:i-STAT/CliniTube</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>pCO2</td><td rowspan=1 colspan=1>p02</td><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>Ca</td><td rowspan=1 colspan=1>Glu</td><td rowspan=1 colspan=1>Hct</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td></tr><tr><td rowspan=1 colspan=1>Sxx</td><td rowspan=1 colspan=1>0.015</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>6.7</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.020</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>0.85</td></tr><tr><td rowspan=1 colspan=1>Sy.</td><td rowspan=1 colspan=1>0.007</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>4.5</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.014</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>0.82</td></tr><tr><td rowspan=1 colspan=1>X min</td><td rowspan=1 colspan=1>7.357</td><td rowspan=1 colspan=1>30.4</td><td rowspan=1 colspan=1>56.5</td><td rowspan=1 colspan=1>135.0</td><td rowspan=1 colspan=1>3.75</td><td rowspan=1 colspan=1>1.210</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>36.0</td></tr><tr><td rowspan=1 colspan=1>X max</td><td rowspan=1 colspan=1>7.478</td><td rowspan=1 colspan=1>48.7</td><td rowspan=1 colspan=1>100.0</td><td rowspan=1 colspan=1>143.5</td><td rowspan=1 colspan=1>4.8</td><td rowspan=1 colspan=1>1.435</td><td rowspan=1 colspan=1>414</td><td rowspan=1 colspan=1>51.0</td></tr><tr><td rowspan=1 colspan=1>average X</td><td rowspan=1 colspan=1>7.425</td><td rowspan=1 colspan=1>39.1</td><td rowspan=1 colspan=1>76.5</td><td rowspan=1 colspan=1>140.5</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>1.273</td><td rowspan=1 colspan=1>122.2</td><td rowspan=1 colspan=1>43.6</td></tr><tr><td rowspan=1 colspan=1>averageY</td><td rowspan=1 colspan=1>7.403</td><td rowspan=1 colspan=1>39.1</td><td rowspan=1 colspan=1>82.3</td><td rowspan=1 colspan=1>139.2</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>1.197</td><td rowspan=1 colspan=1>122.4</td><td rowspan=1 colspan=1>40.2</td></tr><tr><td rowspan=1 colspan=1>average(Yij-Xij)</td><td rowspan=1 colspan=1>-0.023</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>6.0</td><td rowspan=1 colspan=1>-1.0</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-0.075</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>-2.3</td></tr></table>

# 5.7 Summary of Clinical Tests Submitted in Support of Substantial Equivalence

# 5.7.1 Blood precision when using Care-Fill capillary tubes as delivery method

We performed six (6) precision studies in two (2) POC locations having six (6) different operators testing from three (3) different pools of blood with $\pmb { \nsimeq 1 0 }$ replicates per study.

A summary of the results is presented in the table below in Figure 5.5.   
Figure 5.5 - Table - Field Trial: Precision Study Summary   

<table><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>Operator</td><td rowspan=1 colspan=1>Param</td><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>pCO2</td><td rowspan=1 colspan=1>p02</td><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>iCa</td><td rowspan=1 colspan=1>Glu</td><td rowspan=1 colspan=1>Hct</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Nursery</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Nursery</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>avg</td><td rowspan=1 colspan=1>7.292</td><td rowspan=1 colspan=1>55.2</td><td rowspan=1 colspan=1>75.0</td><td rowspan=1 colspan=1>132.1</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>0.873</td><td rowspan=1 colspan=1>52.7</td><td rowspan=1 colspan=1>22.1</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Nursery</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.009</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.013</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Nursery</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.1%</td><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>4.1%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>3.2%</td><td rowspan=1 colspan=1>2.6%</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Nursery</td><td rowspan=1 colspan=1>POC Tech</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Nursery</td><td rowspan=1 colspan=1>POC Tech</td><td rowspan=1 colspan=1>avg</td><td rowspan=1 colspan=1>7.289</td><td rowspan=1 colspan=1>54.8</td><td rowspan=1 colspan=1>72.2</td><td rowspan=1 colspan=1>131.4</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>0.860</td><td rowspan=1 colspan=1>52.3</td><td rowspan=1 colspan=1>21.9</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Nursery</td><td rowspan=1 colspan=1>POC Tech</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.006</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.009</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Nursery</td><td rowspan=1 colspan=1>POC Tech</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.1%</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>0.4%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>2.9%</td><td rowspan=1 colspan=1>1.4%</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>avg</td><td rowspan=1 colspan=1>7.388</td><td rowspan=1 colspan=1>43.0</td><td rowspan=1 colspan=1>156.8</td><td rowspan=1 colspan=1>138.6</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>1.124</td><td rowspan=1 colspan=1>143.3</td><td rowspan=1 colspan=1>39.1</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.012</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>7.1</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.028</td><td rowspan=1 colspan=1>2.8</td><td rowspan=1 colspan=1>0.8</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.2%</td><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>4.5%</td><td rowspan=1 colspan=1>0.5%</td><td rowspan=1 colspan=1>2.2%</td><td rowspan=1 colspan=1>2.5%</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>2.0%</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN 1</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>avg</td><td rowspan=1 colspan=1>7.387</td><td rowspan=1 colspan=1>43.8</td><td rowspan=1 colspan=1>157.0</td><td rowspan=1 colspan=1>139.0</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>1.137</td><td rowspan=1 colspan=1>144.0</td><td rowspan=1 colspan=1>39.8</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.008</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>9.1</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.025</td><td rowspan=1 colspan=1>5.1</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.1%</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>5.8%</td><td rowspan=1 colspan=1>0.5%</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>2.2%</td><td rowspan=1 colspan=1>3.5%</td><td rowspan=1 colspan=1>2.6%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>avg</td><td rowspan=1 colspan=1>7.624</td><td rowspan=1 colspan=1>25.5</td><td rowspan=1 colspan=1>85.7</td><td rowspan=1 colspan=1>149.8</td><td rowspan=1 colspan=1>6.7</td><td rowspan=1 colspan=1>0.948</td><td rowspan=1 colspan=1>222.3</td><td rowspan=1 colspan=1>48.0</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.013</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>6.3</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>0.24</td><td rowspan=1 colspan=1>0.012</td><td rowspan=1 colspan=1>8.6</td><td rowspan=1 colspan=1>1.4</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RN</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.2%</td><td rowspan=1 colspan=1>2.8%</td><td rowspan=1 colspan=1>7.4%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>3.5%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>3.9%</td><td rowspan=1 colspan=1>2.9%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RT</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RT</td><td rowspan=1 colspan=1>avg</td><td rowspan=1 colspan=1>7.621</td><td rowspan=1 colspan=1>26.0</td><td rowspan=1 colspan=1>82.5</td><td rowspan=1 colspan=1>150.2</td><td rowspan=1 colspan=1>6.8</td><td rowspan=1 colspan=1>0.948</td><td rowspan=1 colspan=1>222.4</td><td rowspan=1 colspan=1>48.0</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RT</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.009</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>5.4</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>0.008</td><td rowspan=1 colspan=1>7.1</td><td rowspan=1 colspan=1>0.7</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>NICU</td><td rowspan=1 colspan=1>RT</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>0.1%</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>6.6%</td><td rowspan=1 colspan=1>0.4%</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>3.2%</td><td rowspan=1 colspan=1>1.4%</td></tr></table>

# 5.7.2 Method comparison with predicate device

The method comparison studies were performed in a field trial at a hospital on patient samples of whole blood at the point of care in four (4) locations: NICU, Wellbaby Nursery and two (2) different outpatient drawing areas. The testing was performed by five (5) phlebotomists in the outpatient drawing areas, three (3) registered nurses (RN) in the Well-baby Nursery and five (5) registered nurses in the NICU. Patient specimens were 12 adult capillary blood samples and 36 neonatal capillary blood samples. The comparative method was the predicate device.

Figure 5.6 - Table - Average readings and biases for Epoc/Care-Fill vs. iSTAT/CLINITUBE   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=8>Y: EPOC/CareFill vs X:i-STAT/CliniTube</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>pCO2</td><td rowspan=1 colspan=1>p02</td><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>Ca</td><td rowspan=1 colspan=1>Glu</td><td rowspan=1 colspan=1>Hct</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>47</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>47</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>47</td></tr><tr><td rowspan=1 colspan=1>Sxx</td><td rowspan=1 colspan=1>0.011</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>0.024</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>0.89</td></tr><tr><td rowspan=1 colspan=1>Sy</td><td rowspan=1 colspan=1>0.008</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>0.020</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>0.75</td></tr><tr><td rowspan=1 colspan=1>X min</td><td rowspan=1 colspan=1>7.328</td><td rowspan=1 colspan=1>26.0</td><td rowspan=1 colspan=1>36.0</td><td rowspan=1 colspan=1>137.0</td><td rowspan=1 colspan=1>3.55</td><td rowspan=1 colspan=1>0.93</td><td rowspan=1 colspan=1>42.5</td><td rowspan=1 colspan=1>31.5</td></tr><tr><td rowspan=1 colspan=1>×max</td><td rowspan=1 colspan=1>7.552</td><td rowspan=1 colspan=1>49.3</td><td rowspan=1 colspan=1>91.0</td><td rowspan=1 colspan=1>149.5</td><td rowspan=1 colspan=1>7.05</td><td rowspan=1 colspan=1>1.35</td><td rowspan=1 colspan=1>147</td><td rowspan=1 colspan=1>61.0</td></tr><tr><td rowspan=1 colspan=1>averageX</td><td rowspan=1 colspan=1>7.408</td><td rowspan=1 colspan=1>36.1</td><td rowspan=1 colspan=1>52.8</td><td rowspan=1 colspan=1>143.3</td><td rowspan=1 colspan=1>4.8</td><td rowspan=1 colspan=1>1.197</td><td rowspan=1 colspan=1>73.1</td><td rowspan=1 colspan=1>47.1</td></tr><tr><td rowspan=1 colspan=1>average Y</td><td rowspan=1 colspan=1>7.387</td><td rowspan=1 colspan=1>38.2</td><td rowspan=1 colspan=1>54.1</td><td rowspan=1 colspan=1>140.8</td><td rowspan=1 colspan=1>4.6</td><td rowspan=1 colspan=1>1.151</td><td rowspan=1 colspan=1>73.6</td><td rowspan=1 colspan=1>42.7</td></tr><tr><td rowspan=1 colspan=1>average(Yij-Xij)</td><td rowspan=1 colspan=1>-0.02</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>-2.5</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>-0.041</td><td rowspan=1 colspan=1>0.53</td><td rowspan=1 colspan=1>-4.5</td></tr></table>

In this study, the glucose results coming from neonatal blood specimens were analyzed separately. The summary of this analysis is given in the table in Figure 5.7.

<table><tr><td rowspan=1 colspan=1>Glucose [mg/dL]</td><td rowspan=1 colspan=1>Y: EPOC/CareFill vs X:i-STAT/CliniTube</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>36</td></tr><tr><td rowspan=1 colspan=1>Sxx</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=1 colspan=1>Syy</td><td rowspan=1 colspan=1>2.1</td></tr><tr><td rowspan=1 colspan=1>intercept</td><td rowspan=1 colspan=1>4.2</td></tr><tr><td rowspan=1 colspan=1>slope</td><td rowspan=1 colspan=1>0.948</td></tr><tr><td rowspan=1 colspan=1>Syx</td><td rowspan=1 colspan=1>2.30</td></tr><tr><td rowspan=1 colspan=1>X min</td><td rowspan=1 colspan=1>42.5</td></tr><tr><td rowspan=1 colspan=1>X max</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>R2</td><td rowspan=1 colspan=1>0.982</td></tr><tr><td rowspan=1 colspan=1>Decision Level 1</td><td rowspan=1 colspan=1>45</td></tr><tr><td rowspan=1 colspan=1>Bias</td><td rowspan=1 colspan=1>1.8</td></tr><tr><td rowspan=1 colspan=1>Bias 95% Conf. Hi</td><td rowspan=1 colspan=1>2.8</td></tr><tr><td rowspan=1 colspan=1>Bias 95% Conf. Lo</td><td rowspan=1 colspan=1>0.9</td></tr><tr><td rowspan=1 colspan=1>Decision Level 2</td><td rowspan=1 colspan=1>180</td></tr><tr><td rowspan=1 colspan=1>Bias</td><td rowspan=1 colspan=1>-5.2</td></tr><tr><td rowspan=1 colspan=1>Bias 95% Conf. Hi</td><td rowspan=1 colspan=1>-1.3</td></tr><tr><td rowspan=1 colspan=1>Bias 95% Conf. Lo</td><td rowspan=1 colspan=1>-9.2</td></tr></table>

# 5.8 Summary of Conclusions Drawn from Non Clinical and Clinical Tests

We conclude from the data presented in section 5.7 that the device performs effectively.

We conclude from the data presented in section 5.8 that the device performs effectively in the hands of the users.

We conclude from the data presented in section 5.7 and 5.8 that the clinical performance of the device when using capillary samples is substantially equivalent to the predicate device: i-STAT Model 300 Portable Clinical Analyzer.

We conclude from the data presented in section 5.8 that that the clinical performance of the epoc glucose test when using neonatal samples is substantially equivalent to the predicate device: i-STAT Model 300 Portable Clinical Analyzer.

Epocal, Inc. c/o Roy Layer 2060 Walkley Rd., Ottawa, Ontario CANADA K1G-3P5

# MAR 3 0 2010

Re: k092849   
Trade/Device Name: epoc Capillary Blood Samples for use with epoc Blood Analysis System   
Regulation Number: 21 CFR 862.1120   
Regulation Name: Blood gases (PCO2, PO2) and blood pH test system   
Regulatory Class: II   
Product Code: CEM, CHL, JGS, JFP, JPI, CGA, GIO   
Dated: March 23, 2010   
Received: March 24, 2010

Dear: Mr. Layer:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class II (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or ( 301 ) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

![](images/94b2d7eda033a60dcd2aba9fd8fcf35276a2ca7207a214f97a7425f25048c9d4.jpg)

Courtney C. Harper, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known): k092849

Device Name: epoc™ Capillary Blood Samples for use with epoc Blood Analysis System

Indications For Use:

The epoc Blood Analysis System is intended for use by trained medical professionals as an in vitro diagnostic device for the quantitative testing of samples of heparinized or unanticoagulated arterial, venous or capillary whole blood in the laboratory or at the point/of care in hospitals, nursing homes or other clinical care institutions.

Care-Fill Capillary Tubes are intended for use with the epoc Blood Analysis system and are used for the collection and dispensing of capillary blood samples with epoc Test Cards.

The Blood Gas Electrolyte (BGE) test card panel configuration includes sensors for Sodium - Na, Potassium - K, Calcium - iCa, pH, $p \mathsf { C O 2 }$ $p { \mathsf { O } } 2$ and Hematocrit - Hct.

The Blood Gas Electrolyte (BGEM) test card panel configuration includes sensors for Sodium - Na, Potassium - K, Calcium - iCa, $\mathfrak { p H }$ $p { \mathsf { C O } } 2$ , $p 0 2$ , Hematocrit - Hct and Glucose - Glu.

Measurement of sodium is used in diagnosis and treatment of diseases involving electrolyte imbalance.

Measurement of potassium is used in diagnosis and treatment of diseases involving electrolyte imbalance.

Measurement of Ionized Calcium is used in diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany.

Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/242bdfe8cf2bf752d6c7e518488cea8babb17b4cb33fb770c2468eeb131eae7c.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

Page 1 of 2

# Indications for Use

510(k) Number (if known): k092849

Dei ame:pillay Bloo Smp e  e Blooalyis s

Indications For Use (continued):

Measurement of pH, $p { \mathrm { C O } } 2$ , $p 0 2$ (blood gases) is used in the diagnosis and treatment of lifethreatening acid-base disturbances.

Measurement of Hct distinguishes normal from abnormal states of blood volume, such as anemia and erythrocytosis.

Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, idiopathic hypoglycemia, and of pancreatic islet cell tumors.

Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/309fbe4898eb1ab939429620eccf46dc0a696c9a9323970691f6590f6974cb1b.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

Page 2 of 2